Substrate
science

Thousands of Previously Uncatalogued Micropeptides Given Formal Name 'Peptideins' and Added to Major Databases

An effort announced today in Nature gives thousands of previously overlooked molecules encoded by the human genome the official name peptideins. The reclassification includes them in major gene and protein databases used by the life-sciences community. Some peptideins have been implicated in diseases including childhood cancers as well as in basic cellular functions.

NA
1 source·May 9, 2:14 PM(20 days ago)·1m read
Thousands of Previously Uncatalogued Micropeptides Given Formal Name 'Peptideins' and Added to Major Databaseslink.springer.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

An effort announced today in Nature gives thousands of molecules encoded by the human genome an official new name — peptideins — and marks their inclusion in major gene and protein databases used by the life-sciences community. The human genome contains around 20,000 genes that hold instructions for making working proteins according to current estimates.

These proteins and the genes that encode them have been excluded from databases of known human genes and proteins.

The code for these proteins was excluded from official genome and protein counts. @Nature reported that some scientists have long suspected there might be thousands more 'dark proteins' with unknown but potentially important roles in cells. Researchers say the rebranding will bring much-needed attention and effort to working out what peptideins do in cells.

Some peptideins have been implicated in diseases including childhood cancers as well as in basic cellular functions. The inclusion in major gene and protein databases is expected to accelerate research into the newly named molecules.

'Dark proteins' hiding in our cells could hold clues to cancer and other diseases.

— @Nature reported The human genome contains around 20,000 genes that hold instructions for making working proteins according to current estimates. However, the code for these proteins was excluded from official genome and protein counts, leaving peptideins outside standard tallies used by scientists worldwide.

Key Facts

Peptideins named and added to databases
An effort announced today in Nature gives thousands of these molecules encoded by the human genome an official new name — peptideins — and marks their inclusion
Human genome gene count
The human genome contains around 20,000 genes that hold instructions for making working proteins according to current estimates.
Prior exclusion from counts
These proteins and the genes that encode them have been excluded from databases of known human genes and proteins. The code for these proteins was excluded from

Potential Impact

  1. 01

    Updated official gene and protein databases reflecting the new peptideins category

  2. 02

    Increased research focus on peptideins and their cellular roles

  3. 03

    Potential acceleration of studies linking peptideins to childhood cancers and basic cellular functions

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count223 words
PublishedMay 9, 2026, 2:14 PM
Bias signals removed2 across 1 outlet
Signal Breakdown
Loaded 1Speculative 1

Related Stories

WHO Director Visits Congo as Ebola Outbreak SpreadsNpr
science4 hrs ago

WHO Director Visits Congo as Ebola Outbreak Spreads

The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.

Npr
France 24
2 sources
FDA Panel Recommends XFG Variant for Fall Covid Shotsmedpagetoday.com
science2 hrs agoDeveloping

FDA Panel Recommends XFG Variant for Fall Covid Shots

Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.

Stat
1 source
Benzinga Publishes Article on Biotech Stocks During Pandemic Recoveryfinance.yahoo.com
science6 hrs agoDeveloping

Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery

Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…

Benzinga
1 source